Universidad de Antioquia
udea.edu.coTotal trials
80
Active
10
Phase 3
11
Total enrollment
14,520
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 4 of 4 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| PCA Ketamine | — | — | — | — | — | 1 | |
| Ketamine | — | — | — | — | 3 | ||
| Arnica Tincture | — | — | — | — | 2 | ||
| Meglumine antimoniate. | — | — | — | — | — | 1 |
Next readouts
- 2024-11-02
- 2026-03-30
- 2029-12
Top conditions
- Healthy Volunteers9
- Pain, Postoperative5
- Leishmaniasis, Cutaneous3
- Malocclusion3
- Insulin Resistance2
- Gingivitis2
- Ketamine Adverse Reaction2
- Postoperative Pain2
Frequently asked questions about Universidad de Antioquia
- How many clinical trials does Universidad de Antioquia have on ClinicalTrials.gov?
- Universidad de Antioquia is listed as the lead sponsor on 80 clinical trials in ClinicalTrials.gov, 10 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Universidad de Antioquia's trials are in Phase 3?
- 11 of Universidad de Antioquia's trials are in Phase 3, spread across 4 active drug programs.
- What therapeutic areas does Universidad de Antioquia focus on?
- Universidad de Antioquia's most-studied conditions on ClinicalTrials.gov are Healthy Volunteers, Pain, Postoperative, Leishmaniasis, Cutaneous, Malocclusion, Insulin Resistance.
- When are Universidad de Antioquia's next clinical trial readouts?
- Universidad de Antioquia has 3 upcoming primary-completion readouts tracked here; the soonest is “Arnica Tincture Fot the Treatment of Cutaneous Leishmaniasis”, expected around 2024-11-02.